-
People can get the Moderna booster if they're 18 or older, and the Pfizer-BioNTech version if they're 12 and up. In both cases, they must wait at least two months since their last COVID vaccine.
-
The inventors of Corbevax said it was cheap, easy to make, effective and safe. They hoped it could bring vaccine equity to countries that can't access costlier shots. Has it lived up to its promise?
-
The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.
-
Americans' life expectancy dropped for the second year in a row and is the biggest drop since the 1920s. COVID-19 is driving the downward trend, according to CDC data.
-
The Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.
-
The Biden administration is pausing its distribution of free COVID-19 tests this week, but you can still order new ones before the end date.
-
These days the world of at-home testing for COVID-19 is confusing. How often do I need to test to see if I'm really positive — or negative? Does a faint line mean I'm less contagious?
-
The vaccine maker alleges that its rivals Pfizer and BioNTech used some patented features of its mRNA technology to develop their COVID vaccines.
-
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
-
These undiagnosed infections could be a major factor in the rapid transmission of the omicron variant, the researchers said.